Abstract
Parkinson’s Disease (PD), a progressive neurodegenerative disorder, primarily manifests with motor symptoms; however, non-motor symptoms such as lower gastrointestinal (GI) disturbances, including constipation and gut dysbiosis, often precede motor symptoms. Understanding the relationship between these GI disturbances and PD progression can enhance early detection and improve patient outcomes. Despite increasing evidence linking gut health to neurodegeneration, the mechanisms by which GI dysfunction influences PD progression remain underexplored. Specifically, the gut-brain axis's role in facilitating alpha-synuclein aggregation and systemic inflammation is not fully understood. This review examines recent literature on lower GI disturbances in PD, focusing on constipation, gut dysbiosis, and the “bottom-up” model of PD progression. Studies evaluating gut microbiome composition, alpha-synuclein deposits in the enteric nervous system, and communication pathways via the vagus nerve are discussed. The review also explores integrative approaches as mitigation strategies that include dietary interventions, prebiotics, probiotics, and emerging therapies like fecal microbiota transplantation. Findings indicate that alpha-synuclein aggregation begins in the gut 5-10 years before motor symptoms manifest. Dysbiosis contributes to chronic inflammation and increased gut permeability, exacerbating neurodegeneration via the gut-brain axis. Integrative therapies targeting gut health, such as high-fiber diets, prebiotics, probiotics, and stress reduction, show promise in alleviating GI symptoms and potentially slowing PD progression. This review highlights the pivotal role of the gut-brain axis in PD pathophysiology. Early identification of GI disturbances may allow for preventive strategies and personalized care. Gut-targeted interventions offer a promising avenue to managing PD holistically, underscoring the need for multidisciplinary approaches in clinical practice. This review fills a critical gap in the existing literature on PD by addressing the underexplored connection between lower GI disturbances and neurodegeneration, specifically through the lens of the gut-brain axis.
